[HTML][HTML] Protein biomarker identification in the CSF of patients with CNS lymphoma

S Roy, SA Josephson, J Fridlyand, J Karch… - Journal of clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Elucidation of the CSF proteome may yield insights into the pathogenesis of CNS
disease. We tested the hypothesis that individual CSF proteins distinguish CNS lymphoma …

The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia

D Geschwind, J Karrim, SF Nelson… - Annals of Neurology …, 1998 - Wiley Online Library
Frontotemporal dementia (FTD) is the most common early‐onset non‐Alzheimer's dementia
(non‐AD). Although the role of the ε4 allele of apolipoprotein E (ApoE) has been well …

The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.

P Naik, J Karrim, D Hanahan - Genes & development, 1996 - genesdev.cshlp.org
In a mouse model of multistage tumorigenesis of islet beta-cells, apoptosis was activated
concomitant with T-antigen oncogene-induced cell proliferation, further increased in the …

Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia

JC Jen, Q Yue, J Karrim, SF Nelson… - Journal of Neurology …, 1998 - jnnp.bmj.com
The SCA6 mutation, a small expansion of a CAG repeat in a calcium channel gene
CACNA1A, was identified in three pedigrees. Point mutations in other parts of the gene …

[HTML][HTML] Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin

KA Jessen, SY Liu, CG Tepper, J Karrim… - Breast Cancer …, 2004 - Springer
Introduction In order to study metastatic disease, we employed the use of two related
polyomavirus middle T transgenic mouse tumor transplant models of mammary carcinoma …

Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model

C Kadoch, EB Dinca, R Voicu, L Chen, D Nguyen… - Clinical Cancer …, 2009 - AACR
Purpose: The prospect for advances in the treatment of patients with primary central nervous
system lymphoma (PCNSL) is likely dependent on the systematic evaluation of its …

P1-034: A retrospective study of patients with advanced non-small cell lung cancer and malignant pleural effusion.

J Karrim, J Hwang, T Jahan, D Jablons… - Journal of Thoracic …, 2007 - jto.org
Background: Prior studies of patients with non-small cell lung cancer (NSCLC) have shown
that those diagnosed with stage IIIB with pleural effusion (PE) have a worse prognosis than …

Advances in the Treatment of Lung Cancer

J Karrim, S Dubey - From Local Invasion to Metastatic Cancer …, 2009 - Springer
Advances in lung cancer research have led to changes in the standard of care. Most of these
advances involve management approaches to nonsmall-cell lung cancer (NSCLC). Cure …

[PDF][PDF] Pathologic Correlates of Primary Central Nervous System Lymphoma Defined in an Orthotopic Xenograft Model

J Karrim, A Shuman, CA Lowell, PA Treseler… - academia.edu
Purpose: The prospect for advances in the treatment of patients with primary central nervous
system lymphoma (PCNSL) is likely dependent on the systematic evaluation of its …

Development and molecular characterization of an intracranial model of invasive cns lymphoma using bioluminescence imaging

C Kadoch, E Dinca, J Karrim, R Voicu, L Chen… - Cancer Research, 2008 - AACR
Abstract 402 Primary central nervous system lymphoma (PCNSL) is an aggressive form of
non-Hodgkin's lymphoma typically associated with a prognosis worse than other localized …